CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Apeloa Pharmaceutical Co Ltd Company Snapshot
Apeloa Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other companies in this sector in China: ChangChun High New Technology Industries (2018 sales of 5.32 billion Chinese Renmimbi [US$751.55 million] of which 89% was Medication), Shandong Xinhua Pharmaceutical Company Limited (5.21 billion Chinese Renmimbi [US$735.35 million] of which 49% was Preparations), and Shenzhen Hepalink Pharmaceutical Group Co Ltd (4.81 billion Chinese Renmimbi [US$679.81 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. Apeloa Pharmaceutical Co Ltd reported sales of 6.38 billion Chinese Renmimbi (US$900.35 million) for the year ending December of 2018. This represents an increase of 14.9% versus 2017, when the company's sales were 5.55 billion Chinese Renmimbi. Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 64%). Sales of Healthcare and Pharmaceutical saw an increase of 15.2% in 2018, from 5.53 billion Chinese Renmimbi to 6.36 billion Chinese Renmimbi. Not all segments of Apeloa Pharmaceutical Co Ltd experienced an increase in sales in 2018: sales of Other fell 53.3% to 11.69 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Apeloa Pharmaceutical Co Ltd
  Stock Performance Chart for Apeloa Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 12.95
(Figures in Chinese Renmimbi)
1 Week 9.5%   13 Weeks 6.7%  
4 Weeks 33.8%   52 Weeks 87.7%  
 
Apeloa Pharmaceutical Co Ltd Key Data:
  Ticker: 000739 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 6,376,397,052
(Year Ending Jan 2019).
Employees: 5,761
  Currency: Chinese Renmimbi Market Cap: 15,261,879,221
  Fiscal Yr Ends: December Shares Outstanding: 1,178,523,492
  Share Type: A Gu Closely Held Shares: 624,304,502
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.